Jarett Berry, MD, MS, FAHA
Associate Professor of Medicine and Clinical Sciences
Dedman Family Scholar in Clinical Care
Division of Cardiology
University of Texas Southwestern Medical Center
Dallas, Texas

Dr. Berry is a Dedman Family Scholar in Clinical Care and an Associate Professor of Medicine and an Associate Professor of Clinical Sciences at UT Southwestern in Dallas, TX. He completed his Medical Degree and Internal Medicine residency at UT Southwestern, and his Clinical Cardiology and research training at Northwestern University in Chicago, IL.

Dr. Berry’s clinical interests include both preventive cardiology and general cardiology where he serves as the Director of Cardiac Rehabilitation and an attending physician in the coronary care unit at Parkland Hospital. He has a nationally recognized research program as a cardiovascular epidemiologist with a particular focus on cardiovascular risk estimation across the lifespan. He has published more than 90 peer-reviewed original papers. He serves as an associate editor for Circulation. He also serves as one of the senior investigators in the Dallas Heart Study and one of the principal investigators of UT Southwestern’s Strategically Focused Research Network funded by the American Heart Association. Dr. Berry’s research has been funded by both the National Institutes of Health and the American Heart Association and his work has been recognized by numerous national awards. He is actively involved in leadership roles for the American Heart Association’s Council on Epidemiology and Prevention. 

PLANNERS
Bryan Taylor, PharmD–has no relevant financial relationships to disclose in relation to the content of this activity.

PRESENTERS
Jarett Berry, MD- has disclosed that he is a consultant for AstraZeneca and Roche; he also receives grant/research support from Abbott, NIH, and Roche. 
Javed Butler, MD, MPH, MBA–has disclosed that he is a consultant for Amgen, Array, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, CVRx, G3 Pharmaceutical, Innolife, Janssen, Luitpold, Medtronic, Merck, Novartis, Relypsa, and Vifor.
Muthiah Vaduganathan, MD, MPH–has disclosed that he is a consultant for Amgen, AstraZeneca, Baxter Healthcare, Bayer AG, Boehringer Ingelheim, and Relypsa and receives grant/research support from KL2/Catalyst Medical Research Investigator Training.

PEER REVIEWERS
Kim Birtcher, MS, PharmD, AACC, FNLA, BCPS-AQ Cardiology, CDE, CLS–has no relevant financial relationships to disclose in relation to the content of this activity.
Debra K. Moser, PhD, RN, FAAN–has no relevant financial relationships to disclose in relation to the content of this activity.
Ambarish Pandey, MD, MSCS–has no relevant financial relationships to disclose in relation to the content of this activity.
Scott Urquhart, PA-C, DFAAPA–has disclosed that he is a consultant for AstraZeneca, Dexcom, Novo Nordisk. and Sanofi. He is a member of the speakers' bureau for AstraZeneca and Novo Nordisk.